The Journal of infectionAdolescentChildFemaleHumansMale
Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trial.
E Kelly, M Greenland, P de Whalley, G C Macaulay, P K Aley, E Plested, S Koleva, J Cotton, J Kinch, T Madupuri, R C Read, M Ramsay, C Cameron, D P J Turner, P Heath
Published: 202610.1016/j.jinf.2025.106663
Abstract
BACKGROUND: The emergence of SARS-CoV2 variants combined with waning vaccine-induced immunity and breakthrough infections has highlighted the need for booster doses to maintain protection against SARS-CoV2 infection and disease. METHODS: Com-COV3 was…
Preview only. Read the full abstract at the source